Abstract #3761

Staging Alzheimer’s Disease Risk by Sequencing Brain Function and Structure, Cerebrospinal Fluid, and Cognition Biomarkers

Guangyu Chen¹, Hao Shu¹, Gang Chen¹, Barney Douglas Ward¹, Piero G Antuono², and Shi-Jiang Li¹

¹biophysics, medical college of wisconsin, milwaukee, WI, United States, ²Neurology, medical college of wisconsin, milwaukee, WI, United States

A robust temporal ordering sequence of biomarkers for staging the Alzheimer’s disease (AD) progression risk is revealed by integrating brain function and structure, cerebrospinal fluid (CSF), and cognition biomarkers into an event-based model. In this study, we found that functional abnormality in the hippocampus and posterior cingulate cortex networks is the earliest event in the preclinical phase of AD, even antedating the detectable CSF Aβ and p-tau abnormalities; this sheds light on the link between preclinical AD status and its symptomatic onset for accurately identifying progressive AD trajectories along the disease course, given the condition that disease onset is insidious.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.